Year All2023202220212020 Date Title Jun 29, 2023 MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals Jun 27, 2023 MEI Pharma Responds to Anson and Cable Car Jun 15, 2023 MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates Jun 13, 2023 MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor Jun 02, 2023 MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successor Jun 01, 2023 MEI Pharma Board of Directors Rejects Unsolicited Proposal May 30, 2023 MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal May 23, 2023 MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell Malignancies May 11, 2023 MEI Pharma Reports Third Quarter Fiscal Year 2023 Results and Operational Highlights Apr 14, 2023 MEI Pharma Announces 1-for-20 Reverse Stock Split Pagination First page « Previous page ‹ Page 1 Page 2 Current page 3 Page 4 Next page › Last page » Displaying 21 - 30 of 32
